METZGER MICHAEL A (President and COO) sold 2.5% of their position (7.53K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market sale worth $70.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/18/2025ACC: 0000950170-25-096947
Officer· President and COO
Since Feb 2019
-7.53K
Net shares
Net seller
$70.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.53K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.53K
Price / share
$9.29
Trade value
$69.95K
% of position
2.5%
7/16/2025
306.19K→298.66K
Total
Net shares
−7.53K
Net value
-$69.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/16/2025 | S · Sale | −7.53K | $9.29 | $69.95K | 2.5% | 306.19K | 298.66K |
| Total | −7.53K | -$69.95K | ||||||
Derivative Transactions0
No derivative transactions reported